Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA

Abstract

THE protein p21 (WAF1, CIP1 or sdil), induced by the tumour-suppressor protein p53, interacts with and inhibits two different targets essential for cell-cycle progression1–8. One of these is the cyclin–Cdk family of kinases and the other is the essential DNA replication factor, proliferating-cell nuclear antigen (PCNA). We report here that separate domains of p21 are responsible for interacting with and inhibiting the two targets. An amino-terminal domain inhibits cyclin–Cdk kinases and a carboxyl-terminal domain inhibits PCNA. Using these separated domains, we have determined that p21 inhibits different biological systems through different targets. The PCNA-binding domain is sufficient for inhibition of DNA replication based on simian virus 40, whereas the Cdk2-binding domain is sufficient for inhibition of DNA replication based on Xenopus egg extract and for growth suppression in transformed human cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Xiong, Y. et al. Nature 366, 701–704 (1993).

    Article  ADS  CAS  Google Scholar 

  2. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. Cell 75, 805–816 (1993).

    Article  CAS  Google Scholar 

  3. el-Deiry, W. et al. Cell 75, 817–825 (1993).

    Article  CAS  Google Scholar 

  4. Gu, Y., Turck, C. W. & Morgan, D. O. Nature 366, 707–710 (1993).

    Article  ADS  CAS  Google Scholar 

  5. Noda, A., Ning, Y., Venable, S. F., Pereira, S. O. & Smith, J. R. Expl Cell Res. 211, 90–98 (1994).

    Article  CAS  Google Scholar 

  6. el-Deiry, W. et al. Cancer Res. 54, 1169–1174 (1994).

    CAS  PubMed  Google Scholar 

  7. Waga, S., Hannon, G. J., Beach, D. & Stillman, B. Nature 369, 574–578 (1994).

    Article  ADS  CAS  Google Scholar 

  8. Flores-Rozas, H. et al. Proc. natn. Acad. Sci. U.S.A. 91, 8655–8659 (1994).

    Article  ADS  CAS  Google Scholar 

  9. Strausfeld, U. P. et al. Curr. biol. 4, 876–883 (1994).

    Article  CAS  Google Scholar 

  10. D'Urso, G., Marraccino, R. L., Marshak, D. R. & Roberts, J. M. Science 250, 786–791 (1990).

    Article  ADS  CAS  Google Scholar 

  11. Dutta, A. & Stillman, B. EMBO J. 11, 2189–2199 (1922).

    Article  Google Scholar 

  12. Li, R., Waga, S., Hannon, G. J., Beach, D. & Stillman, B. Nature 371, 534–537 (1994).

    Article  ADS  CAS  Google Scholar 

  13. Dulic, V. et al. Cell 76, 1013–1023 (1994).

    Article  CAS  Google Scholar 

  14. Polyak, K. et al. Cell 78, 59–66 (1994).

    Article  CAS  Google Scholar 

  15. Toyoshima, H. & Hunter, T. Cell 78, 67–74 (1994).

    Article  CAS  Google Scholar 

  16. Dutta, A., Ruppert, J. M., Aster, J. C. & Winchester, E. Nature 365, 79–82 (1993).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, J., Jackson, P., Kirschner, M. et al. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374, 386–388 (1995). https://doi.org/10.1038/374386a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/374386a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing